Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
42.93B | 43.75B | 42.29B | 41.92B | 43.46B | 49.08B | Gross Profit |
3.33B | 3.66B | 3.92B | 4.30B | 3.42B | 2.80B | EBIT |
1.12B | 1.42B | 1.18B | 2.24B | 1.50B | 819.51M | EBITDA |
943.71M | 1.42B | 932.37M | 1.68B | 1.18B | 835.33M | Net Income Common Stockholders |
336.15M | 642.78M | 292.55M | 897.50M | 748.17M | 497.46M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.04B | 6.59B | 5.97B | 4.19B | 6.33B | 6.24B | Total Assets |
19.21B | 16.64B | 18.58B | 16.86B | 20.89B | 20.40B | Total Debt |
8.49B | 5.97B | 8.09B | 6.35B | 11.44B | 11.10B | Net Debt |
2.45B | -623.37M | 2.12B | 2.17B | 5.11B | 4.86B | Total Liabilities |
12.11B | 9.23B | 11.50B | 9.91B | 14.50B | 14.63B | Stockholders Equity |
7.10B | 7.40B | 7.08B | 6.93B | 6.38B | 5.77B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.05B | 1.02B | 4.56B | 746.32M | -604.69M | Operating Cash Flow |
0.00 | 3.07B | 1.03B | 4.58B | 747.66M | -602.42M | Investing Cash Flow |
0.00 | -39.26M | -70.61M | -15.93M | 7.76M | 1.85M | Financing Cash Flow |
0.00 | -2.46B | 473.04M | -6.77B | -866.74M | 862.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥26.19B | 7.94 | 3.82% | 3.61% | -14.91% | ||
74 Outperform | ¥5.58B | 8.25 | 4.55% | 3.45% | 128.48% | ||
74 Outperform | ¥26.00B | 7.53 | 1.94% | 36.47% | 454.91% | ||
62 Neutral | $11.80B | 10.10 | -7.47% | 2.99% | 7.37% | -8.16% | |
55 Neutral | ¥3.45B | 160.51 | ― | 50.79% | -59.24% | ||
52 Neutral | ¥4.39B | 31.45 | 1.51% | -8.12% | -102.86% | ||
52 Neutral | ¥13.07B | ― | 4.69% | -6.97% | 45.07% |